1. Supplementary Figure 1 Venkatachalam et al. 2013 ab a ab abc c 24 48 72 96 120 Hours after FB17 treatment

2. Supplementary Figure 2 Venkatachalam et al. 2013 At1g11610 At3g28360 At1g21240 At3g14460 At3g20190 UBQ1 FB17 - + - + - + - + - + - + - + - + - + - + at3g20190 at3g14460 at1g21240 at1g11610 Col-0 Col-0 Col-0 Col-0 Col-0 at3g28360

3. Supplementary Figure 3 Venkatachalamet al. 2013 Col-0 Col-0 Col-0 Col-0 Col-0 At5g56320 At5g43350 At4g19690 At5g01220 At3g27980 UBQ1 FB17 - + - + - + - + - + - + - + - + - + - + at5g43350 at5g56320 at4g19690 at5g01220 at3g27980

4. Supplementary Figure 4 Venkatachalam et al. 2013 Col-0 at2g47620 at2g33160 at2g40930 at2g26540 at5g12350 at5g19460 at5g19830 at5g13120 at5g09480